Pheast Therapeutics
Jen Cao has extensive experience in immuno-oncology, myeloid cells, functional genetic screening, and target identification. Jen has held positions such as Director of Translational Science, Director of Discovery, and Associate Director of Discovery at various biotech and pharmaceutical companies. With a background in molecular genetics and a Ph.D. in the field, Jen has been involved in a variety of research areas including cancer biology, drug resistance, and protein/antibody engineering. Additionally, Jen has experience in equity research and investment banking within the biotechnology and healthcare sectors.
This person is not in any offices
Pheast Therapeutics
Pheast Therapeutics is a cancer immunotherapy company focused on developing novel checkpoint therapies to harness the innate immune system in the fight against cancer.